mSystemsMicrobiologyPeer-reviewed journal article
PhoPQ-mediated lipopolysaccharide modification regulates intrinsic resistance to tetracycline and glycylcycline antibiotics in Escherichia coli
Abstract
Tetracyclines and glycylcycline are among the last-resort antibiotics used to combat infections caused by multidrug-resistant Gram-negative pathogens. Despite the clinical importance of these antibiotics, their mechanisms of resistance remain unclear. In this study, we elucidated a novel mechanism of resistance to tetracycline and glycylcycline antibiotics via lipopolysaccharide (LPS) modification. Disruption of the Escherichia coli PhoPQ two-component system, which regulates the transcription of various genes involved in magnesium transport and LPS modification, leads to increased susceptibility to tetracycline, minocycline, doxycycline, and tigecycline. These phenotypes are caused by enhanced expression of phosphoethanolamine transferase EptB, which catalyzes the modification of the inner core sugar of LPS. PhoPQ-mediated regulation of EptB expression appears to affect the intracellular transportation of doxycycline. Disruption of EptB increases resistance to tetracycline and glycylcycline antibiotics, whereas the other two phosphoethanolamine transferases, EptA and EptC, that participate in the modification of other LPS residues, are not associated with resistance to tetracyclines and glycylcycline. Overall, our results demonstrated that PhoPQ-mediated modification of a specific residue of LPS by phosphoethanolamine transferase EptB regulates resistance to tetracycline and glycylcycline antibiotics. ImportanceElucidating the resistance mechanisms of clinically important antibiotics helps in maintaining the clinical efficacy of antibiotics and in the prescription of adequate antibiotic therapy. Although tetracycline and glycylcycline antibiotics are clinically important in combating multidrug-resistant Gram-negative bacterial infections, their mechanisms of resistance are not fully understood. Our research demonstrates that the Escherichia coli two-component system PhoPQ regulates resistance to tetracycline and glycylcycline antibiotics by controlling the expression of phosphoethanolamine transferase EptB, which catalyzes the modification of the inner core residue of lipopolysaccharide (LPS). Therefore, our findings highlight a novel resistance mechanism to tetracycline and glycylcycline antibiotics and the physiological significance of LPS core modification in E. coli. One sentence summaryLipopolysaccharide modification-mediated tigecycline resistance
- organism: E. coli
- research focus: host-pathogen & immune response
- research focus: cell signaling & trafficking
- research focus: gene regulatory network inference
- approach: experimental assay
- Citations
- 8
- FWCI
- 1.42
- Field percentile
- top 21%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The QseB response regulator imparts tolerance to positively charged antibiotics by controlling metabolism and minor changes to LPS
M. N. Hurst, C. J. Beebout, … M. Hadjifrangiskou·bioRxiv·Jan 10, 2023
- High-level carbapenem tolerance requires antibiotic-induced outer membrane modifications.
A. N. Murtha, M. I. Kazi, … T. Dörr·bioRxiv·Sep 25, 2021
- Yersinia pseudotuberculosis doxycycline tolerance strategies include modulating expression of genes involved in cell permeability and tRNA modifications
H. S. Alvarez-Manzo, R. K. Davidson, … K. M. Davis·bioRxiv·Nov 1, 2021
- Synergy between Group 2 capsules and lipopolysaccharide underpins serum resistance in Extra-intestinal Pathogenic Escherichia coli
Naoise McGarry, Domhnall Roe, Stephen G. J. Smith·MicrobiologyPeer-reviewed·Aug 23, 2024
- Colistin resistance in Escherichia coli confers protection of the cytoplasmic but not outer membrane from the polymyxin antibiotic
M. Humphrey, G. Larrouy-Maumus, … A. M. Edwards·bioRxiv·Jul 21, 2021
- Lysine acetylation regulates antibiotic resistance in Escherichia coli